News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
474,002 Results
Type
Article (22303)
Company Profile (87)
Press Release (451592)
Multimedia
Podcasts (81)
Webinars (21)
Section
Business (142090)
Career Advice (1358)
Deals (22553)
Drug Delivery (95)
Drug Development (56890)
Employer Resources (87)
FDA (12523)
Job Trends (9702)
News (218584)
Policy (21265)
Tag
2027 BioCapital Standard (2)
2027 BioMidwest Digital (1)
2027 BioMidwest Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (5)
2027 Pharm Country Digital (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
40 Under 40 (1)
Academia (1918)
Accelerated approval (71)
ADA (36)
Adcomms (37)
Allergies (172)
Alliances (34956)
ALS (232)
Alzheimer's disease (1624)
Antibody-drug conjugate (ADC) (638)
Approvals (13057)
Artificial intelligence (894)
ASCO (302)
Autoimmune disease (410)
Automation (74)
Bankruptcy (168)
Belgium (14)
Best Places to Work (8554)
BIO (68)
Biologics (37)
BIOSECURE Act (8)
Biosimilars (209)
BioSpace Insights (97)
Biotechnology (72)
Bispecific (10)
Bladder cancer (199)
Brain cancer (86)
Breast cancer (838)
Cancer (6682)
Cardiovascular disease (474)
Career advice (1149)
Career pathing (31)
CAR-T (359)
CDC (29)
CDMO (142)
Celiac Disease (2)
Cell-line development (2)
Cell therapy (1023)
Cervical cancer (56)
Clinical research (52468)
Collaboration (2515)
Commercialization (25)
Company closure (7)
Compensation (1462)
Complete response letters (114)
COVID-19 (1720)
CRISPR (122)
CRO (1)
C-suite (1450)
Cystic fibrosis (151)
Data (8683)
Decentralized trials (4)
Denatured (19)
Depression (167)
Dermatology (146)
Diabetes (597)
Diagnostics (5693)
Digital health (62)
Diversity (6)
Diversity, equity & inclusion (26)
Drug discovery (432)
Drug pricing (72)
Drug shortages (13)
Duchenne muscular dystrophy (301)
Earnings (53289)
Editorial (32)
Employer branding (9)
Employer resources (78)
Events (68782)
Executive appointments (1162)
Eye disease (4)
FDA (16883)
Fibrodysplasia Ossificans Progressiva (13)
Fragile X (1)
Friedreich's ataxia (24)
Frontotemporal dementia (34)
Funding (2075)
Gene editing (256)
Generative AI (81)
Gene therapy (772)
GLP-1 (733)
Government (2741)
Grass and pollen (5)
Guidances (392)
Healthcare (13088)
Hematology (175)
HIV (98)
Huntington's disease (66)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (121)
Immunology and inflammation (274)
Immuno-oncology (128)
Indications (233)
Infectious disease (2049)
Inflammatory bowel disease (223)
Inflation Reduction Act (6)
Influenza (131)
Intellectual property (340)
Interviews (275)
IPO (11351)
IRA (16)
Job creations (1480)
Job search strategy (900)
JPM (44)
Kidney cancer (28)
Kidney disease (98)
Labor market (66)
Layoffs (340)
Leadership (34)
Legal (3094)
Licensing (51)
Liver cancer (102)
Longevity (43)
Lung cancer (952)
Lung diease (15)
Lymphoma (461)
Machine learning (69)
Management (29)
Manufacturing (1246)
Marketing (15)
MASH (212)
Medical affairs (2)
Medical device (10165)
Medtech (10407)
Mergers & acquisitions (12584)
Metabolic disorders (1375)
mRNA (237)
Multiple sclerosis (179)
Multispecific (3)
NASH (16)
Netherlands (15)
Neurodegenerative disease (479)
Neuropsychiatric disorders (100)
Neuroscience (3287)
Neurotech (2)
NextGen: Class of 2026 (4014)
Non-profit (3094)
Now hiring (26)
Obesity (552)
Opinion (238)
Ovarian cancer (255)
Pain (255)
Pancreatic cancer (372)
Parkinson's disease (407)
Partnered (42)
Patents (676)
Patient advocacy (1)
Patient recruitment (859)
Patient selection (39)
Peanut (58)
People (39232)
Peptides (19)
Pharmaceutical (17)
Pharmacy benefit managers (14)
Phase 1 (17082)
Phase 2 (22781)
Phase 3 (18004)
Pipeline (11675)
Policy (182)
Postmarket research (1100)
Preclinical (6604)
Press Release (63)
Prostate cancer (347)
Psychedelics (62)
Radioligand (2)
Radiopharmaceuticals (374)
Rare diseases (1272)
Real estate (3113)
Recruiting (34)
Regenerative medicine (12)
Regulatory (21473)
Reports (53)
Research institute (1850)
Resumes & cover letters (283)
Rett syndrome (54)
RNA editing (31)
RSV (63)
Schizophrenia (162)
Series A (366)
Series B (262)
Service/supplier (5)
Sickle cell disease (112)
Special edition (21)
Spinal muscular atrophy (137)
Sponsored (41)
Startups (2552)
State (2)
Stem cells (1)
Stomach cancer (19)
Substance use disorders (18)
Supply chain (105)
Switzerland (1)
Tariffs (34)
The Weekly (61)
Vaccines (844)
Venture capital (98)
Weight loss (285)
Wet AMD (4)
Women's health (119)
Worklife (7)
Date
Today (104)
Last 7 days (598)
Last 30 days (2483)
Last 365 days (27414)
2026 (21205)
2025 (25758)
2024 (28485)
2023 (32108)
2022 (41028)
2021 (42993)
2020 (39319)
2019 (31547)
2018 (23136)
2017 (22458)
2016 (19753)
2015 (22646)
2014 (16062)
2013 (13019)
2012 (14071)
2011 (14340)
2010 (12632)
Location
Africa (437)
Alabama (103)
Alaska (5)
Arizona (259)
Arkansas (15)
Asia (28785)
Australia (4767)
California (13047)
Canada (3912)
China (1651)
Colorado (548)
Connecticut (612)
Delaware (402)
Europe (63686)
Florida (2070)
Georgia (428)
Hawaii (4)
Idaho (42)
Illinois (997)
India (113)
Indiana (617)
Iowa (29)
Japan (667)
Kansas (128)
Kentucky (39)
Louisiana (51)
Maine (72)
Maryland (1476)
Massachusetts (9617)
Michigan (355)
Minnesota (563)
Mississippi (5)
Missouri (142)
Montana (29)
Nebraska (21)
Nevada (144)
New Hampshire (76)
New Jersey (3339)
New Mexico (32)
New York (3479)
North Carolina (1729)
North Dakota (12)
Northern California (6749)
Ohio (397)
Oklahoma (24)
Oregon (29)
Pennsylvania (2570)
Puerto Rico (28)
Rhode Island (49)
South America (614)
South Carolina (92)
South Dakota (2)
Southern California (5224)
Tennessee (216)
Texas (2243)
United States (46305)
Utah (413)
Vermont (2)
Virginia (334)
Washington D.C. (49)
Washington State (1023)
West Virginia (3)
Wisconsin (163)
Wyoming (3)
474,002 Results for "advanced accelerator applications".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lung cancer
Merck, Daiichi Sankyo retract accelerated approval request for lung cancer ADC
Merck and Daiichi Sankyo’s withdrawal of an accelerated approval request for the antibody-drug conjugate ifinatamab deruxtecan is a “net positive” for rivals like GSK and Roche, according to RBC Capital Markets.
September 28, 2026
·
2 min read
·
Tristan Manalac
Press Releases
IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications
September 2, 2026
·
4 min read
Press Releases
SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability
October 1, 2026
·
7 min read
Press Releases
10x Genomics Announces New Collaboration to Advance Single Cell and Spatial Applications Across Solid Tumors and Blood Cancers
October 7, 2026
·
5 min read
Press Releases
Verasonics Announces International Patent Grants and New Provisional Patent Application for Advanced Ultrasound Transceiver Technology
September 2, 2026
·
2 min read
Press Releases
Battelle Advances Biothreat Detection with Novel Spray-Based Technology Developed for Defense Applications
August 27, 2026
·
3 min read
Press Releases
Compvide™ Announces Strategic Collaboration with OpZira™ to Accelerate Growth and Advance the CIMED™ Platform
July 16, 2026
·
2 min read
Regulatory
FDA opens Operation TrialBlazer for applications, hoping to reshore early trials
The FDA aims to leverage the expertise of qualified research institutions paired with drug sponsors to lessen the risk of clinical holds during the investigational new drug review process and expedite the path to first-in-human development in the U.S. The initial application period will close on Oct. 30.
September 15, 2026
·
1 min read
·
Heather McKenzie
Press Releases
Harbour BioMed Announces NMPA Approval of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors
August 18, 2026
·
3 min read
Press Releases
Nabsys and Indiana University Collaborate to Advance Electronic Genome Mapping Applications in Hematologic Malignancies
August 2, 2026
·
4 min read
1 of 47,401
Next